Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors

Abroad (travel likely)Recruiting

Conditions

Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Study coordinator (Kym Warner) · Kymberlyn.Warner@UHhospitals.org · 216-844-7546

Study leads

Neil Korman, MD
Principal Investigator
University Hospitals Cleveland Medical Center
Jordan K Kahle, MD
Principal Investigator
University Hospitals Cleveland Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Psoriasis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects

Psoriasis

Abroad (travel likely)RecruitingPHASE2

Mexico City, Mexico

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Nanjing, China